p53-LNP Designer is a computational platform for exploring and predicting lipid nanoparticle (LNP) formulations for TP53/p53-based cancer therapeutics.
The platform connects:
- TP53 mutations
- Cancer type
- mRNA cargo
- Ionizable lipid properties
- LNP formulation parameters
- Predicted delivery characteristics
- Cancer-specific targeting strategies
Research software: Computational predictions are intended for research and hypothesis generation and should not be interpreted as experimentally validated formulations or clinical recommendations.
Lipid nanoparticles are an important delivery technology for nucleic-acid therapeutics, including mRNA. Selecting an appropriate ionizable lipid and formulation composition remains a challenging optimization problem.
p53-LNP Designer aims to provide an in silico workflow for evaluating and ranking candidate LNP formulations.
TP53 Mutation
|
v
Cancer Type + Cargo
|
v
Lipid Library
|
+-- pKa
+-- logP
+-- Charge
+-- Structure
+-- Molecular Descriptors
|
v
Formulation Prediction
|
+-- Encapsulation Efficiency
+-- Particle Size
+-- PDI
+-- Endosomal Escape
|
v
Targeting Strategy
|
v
Ranked Formulation Candidates
|
v
Research Report